New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published: November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like Mapping the mysteries: Study reveals surprising hubs of human immune cells October 24, 2023 Advancing pulmonary fibrosis treatment through targeted drug delivery April 14, 2025 Insilico Medicine doses first patient in Phase I Trial of ISM6331 for mesothelioma January 22, 2025